No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease. - Wikidata - thesis-toulmin - TriplyDB

No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.

No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.

http://www.wikidata.org/entity/Q33920648

about

Phosphorus and the kidney: What is known and what is needed Phosphate binders in chronic kidney disease: a systematic review of recent data.The use of fibroblast growth factor 23 testing in patients with kidney disease.A novel fluorescent probe-based flow cytometric assay for mineral-containing nanoparticles in serum.Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting.The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis Cost-effectiveness of phosphate binders among patients with chronic kidney disease not yet on dialysis: a long way to go.Epidemiology of low-proteinuric chronic kidney disease in renal clinics Con: Phosphate binders in chronic kidney disease A within-patient analysis for time-varying risk factors of CKD progression.Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.Dietary phosphorus and kidney disease.Novel iron-containing phosphate binders for treatment of hyperphosphatemia.SELF-REPORTED MEDICATION ADHERENCE IN PATIENTS WITH END-STAGE KIDNEY DISEASE UNDERGOING ONLINE-HAEMODIAFILTRATION.Association between plasma phosphorus and renal outcome: A prospective cohort of patients majorly with glomerulonephritis.A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKD.Ferritin Elevation and Improved Responsiveness to Erythropoiesis-Stimulating Agents in Patients on Ferric Citrate Hydrate.Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.Predictors of health-related quality of life perceived by end-stage renal disease patients under online hemodiafiltration.End-stage renal disease adherence questionnaire: translation and validation to the portuguese language.Nicotinic acid and related compounds: A meta-analysis of their use for hyperphosphatemia in dialysis patients.

P2860

Q26992251-73F3A870-7A29-4719-B716-F112D6DF1A7D Q31039292-3E06D3BA-8B07-49E0-8C23-07B79068BA3A Q33835743-987EAAED-A9B5-4063-8FED-4692880E9C90 Q33916132-3EE8D54D-3065-465C-964F-D6391C6B942E Q34254746-A1411DBA-4EEB-4832-B2A2-C46C90BBC6C0 Q36001789-9A397DBB-928E-46B8-A9BD-85D4C79F4430 Q36071962-68E9ECBC-9531-4F91-AD1A-33A214A6D0FF Q36284146-AA576481-0C30-41C4-A8B4-783A89BDCE38 Q36497902-CCD0D38B-A745-4B07-805A-4302E6865F1A Q37604738-15A15E95-B050-403C-AC75-87B615D1E2B7 Q37673143-9BBBBC03-568B-494D-82D9-24D25B46F270 Q38123246-6EFD9685-4D5A-4021-94A7-778C72C1AEDE Q38570622-597EB763-E76A-4CD4-9BBE-250B570CEF43 Q40106865-8DC9DE65-5D84-4546-8DA2-C4C63C7D3DF2 Q40975606-C4B1465D-CF51-4645-851B-C59C29FB2346 Q42060514-64F487E4-B0A0-4DD6-A276-7E959F6CE38F Q45853530-C642F6CD-87D3-430D-A8F8-862715684499 Q46004871-02DEC933-1CAF-4C19-B023-F5B3E3093C19 Q46155646-85F1CC2D-4D88-4146-8646-3BA3D5EADE0E Q48964213-7F8054AD-24DD-412B-BDB0-FAD1D9F6CE07 Q55035309-2596E56C-097C-4E91-ACDD-06DFEC3198EB

P2860

No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.

http://www.wikidata.org/entity/Q33920648

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

No independent association of ...... en for chronic kidney disease.

@ast

No independent association of ...... en for chronic kidney disease.

@en

type

label

No independent association of ...... en for chronic kidney disease.

@ast

No independent association of ...... en for chronic kidney disease.

@en

prefLabel

No independent association of ...... en for chronic kidney disease.

@ast

No independent association of ...... en for chronic kidney disease.

@en

P1433

Q33920648-38391C98-40D5-4C10-BC7D-8CFACE3F69D2

P1476

Q33920648-57060459-AEBE-4F77-8800-E05F6184FD91

P2093

Q33920648-12E4C6CD-5587-40F8-8054-678198BE3302

Q33920648-1B4FC2CC-0BD2-410E-99B7-1FB25F0F2C62

Q33920648-20131F37-8697-40D4-94B8-1CD627A3AD1B

Q33920648-67024F2B-3AE7-44E8-BF55-9683BE02B9C5

Q33920648-BD83F7CC-F0B0-49B2-941F-BE36F22EF73C

Q33920648-D06206EC-F275-4AB2-974B-F4D8D47B3E37

Q33920648-F2BF08E5-7852-4575-B5F8-C2BE7F75F8EF

Q33920648-F47E4B23-C8DE-434D-A33E-A81D208BECE6

P2860

Q33920648-0974D3FC-C035-404E-9314-9BF1639FF21C

Q33920648-19AE6029-DCBC-4B38-B19B-F5BD60DDCF45

Q33920648-2010A862-FC2D-4264-AC8A-DB5670A37ECB

Q33920648-202FDB0D-A7F9-4EBA-8674-3B5C02172940

Q33920648-206E9101-A688-401C-8652-B3DB84FEB4ED

Q33920648-25C676C1-2A41-426B-9086-FF21D57ADD67

Q33920648-294CBBD7-792C-42FA-BCEC-8CB497D29F37

Q33920648-34506026-D020-4FDE-99D9-8A008950037A

Q33920648-390744F6-CFC3-4C62-B0F5-7DE3FBDC5C70

Q33920648-3CB35613-56C0-4DA8-ACC4-E628C56FA6B5

P2888

Q33920648-327B6096-6C72-44D7-A003-CA868C668404

P304

Q33920648-D28F5919-C574-4F3A-87D7-C62D1C9FCC55

P31

Q33920648-9C22238E-A451-4BB3-A307-FBF9E9A877C5

P356

Q33920648-3CDE75DA-B30A-4FE2-93B3-F5CD75A49596

P407

Q33920648-99228998-A789-4510-BC76-FB2AAD1EA17E

P433

Q33920648-5889051C-48C8-437C-8C3C-1B5A5C81FC98

P478

Q33920648-BB62DBF4-455E-445A-B0E2-C8502CB01A5A

P50

Q33920648-73DF9EDA-285B-474B-AD62-BD0EC9499C78

Q33920648-A14A6FC4-9F39-43C7-8F3F-C3658C9E7271

Q33920648-AC2ACAF9-218F-4CA8-B50F-93B96A19A575

Q33920648-DD9A32A5-3928-42E4-B164-256D6690BB6F

P577

Q33920648-7B077780-F0F5-469C-BB2A-BFEBB49A77B6

P5875

Q33920648-C6D6ED48-69C8-487F-BCDD-9F813E8F6674

P6179

Q33920648-C0A43C5A-9927-4A0C-B223-C08D2F42B7C4

P698

Q33920648-7687DBC7-B0C7-4A1D-A3B3-2A2B2EA8447C

P932

Q33920648-B7DDFB89-F1A6-4899-8C81-94FCC837844A

P356

P1433

Kidney International

P1476

No independent association of ...... en for chronic kidney disease.

@en

P2093

Anuja Shah

http://www.w3.org/2001/XMLSchema#string

Carmen A Peralta

http://www.w3.org/2001/XMLSchema#string

Georges Saab

http://www.w3.org/2001/XMLSchema#string

Keith Norris

http://www.w3.org/2001/XMLSchema#string

Kidney Early Evaluation Program (KEEP) Investigators

http://www.w3.org/2001/XMLSchema#string

Peter A McCullough

http://www.w3.org/2001/XMLSchema#string

Shu-Cheng Chen

http://www.w3.org/2001/XMLSchema#string

Suying Li

http://www.w3.org/2001/XMLSchema#string

P2860

Hyperphosphatemia of chronic kidney disease

A new equation to estimate glomerular filtration rate

Phosphate regulation of vascular smooth muscle cell calcification

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey.

Prevalence and prognostic significance of renal artery calcification in patients with diabetes and proteinuria

Low socioeconomic status associates with higher serum phosphate irrespective of race

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

The mechanism of phosphorus as a cardiovascular risk factor in CKD

P2888

P304

989-997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2013.145

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

Adam T Whaley-Connell

Rajnish Mehrotra

Michael C Sachs

Bryan R Kestenbaum

P577

2013-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236327978

http://www.w3.org/2001/XMLSchema#string

P6179

1026854018

http://www.w3.org/2001/XMLSchema#string

P698

23615501

http://www.w3.org/2001/XMLSchema#string

P932

4103660

http://www.w3.org/2001/XMLSchema#string